Modifications in Mutational Landscape in Patients with Lower Risk MDS without 5Q Deletion Receiving Azacitidine Are Correlated with Clinical Response
Year: 2017
Type: article
Source: Leukemia Research
Authors: J. Sanchez-Garcia, J.M. Hernandez-Sanchez, J. Falantes, R. Benito, A. Medina, E. Lumbreras, F. Hernandez-Mohedo, L. Hermosin, A. Bailen, S. Maria, J. Casaño, C. Calderon, M. Labrador-Mateo, J. Serrano, J.M. Hernandez-Rivas
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2611766670
